Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride effectively reduces hair growth in women with idiopathic hirsutism, but requires careful contraception during treatment.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

Women with acne have lower levels of a specific hormone marker than women without acne.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

Hormonal treatments can help with acne, especially in women, by lowering androgen levels or blocking their effects.

Antiandrogens can treat female hormonal conditions, but environmental ones may harm reproductive health.

Spironolactone is a safe and effective treatment for reducing excessive hair growth in women.

Hormones, especially androgens, play a big role in acne, but most acne sufferers don't have a hormone disorder. Hormonal treatments, including birth control pills, can be very effective for women whose acne doesn't improve with regular treatments.

Spironolactone plus finasteride reduces hirsutism more effectively.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Dihydrotestosterone can be made from dehydroepiandrosterone in skin cells without needing testosterone.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

Dihydrotestosterone (DHT) stops hair growth in mice by lowering a growth factor important for hair.

Steroidogenic isoenzymes may help improve treatments for common hair loss.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

The document concludes that careful evaluation is needed to diagnose PCOS correctly due to similar symptoms in other conditions, and accurate testosterone level measurement is crucial.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

Hirsutism, excessive hair growth in women, is often caused by PCOS and can be managed with medication and personalized treatment plans.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

The chapter explains the causes of excessive hair growth and masculinization in women and how to measure hormone levels related to these conditions.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

High testosterone increases heart disease risk in women with PCOS.

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.

PCOS is caused by both genetics and environmental factors like diet and obesity.

Obesity is linked to various skin problems and may increase the risk of skin cancer.